StockData

Nika Pharmaceuticals, Inc (NIKA) stock

NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 0/30
$0.41+0.00 (0.00%)

Close on Oct 16, 2026Market cap $431.19MP/E –Yield –

Nika Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Nika Pharmaceuticals's total assets was $9.94K at Jun 30, 2026. For fiscal 2025 it was $21.00K, up 17.1% from the year before. The highest annual figure on record is $21.00K in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$21.00K+17.1%
FY2024Dec 31, 2024$17.93K-8.5%
FY2023Dec 31, 2023$19.60K+2168.1%
FY2022Dec 31, 2022$864+116.5%
FY2021Dec 31, 2021$399-75.2%
FY2020Dec 31, 2020$1.61K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.94K-68.5%
Q1 FY2026Mar 31, 2026$20.64K-41.0%
Q4 FY2025Dec 31, 2025$21.00K+17.1%
Q3 FY2025Sep 30, 2025$23.63K+1604.5%
Q2 FY2025Jun 30, 2025$31.61K-23.8%
Q1 FY2025Mar 31, 2025$34.99K+78.5%
Q4 FY2024Dec 31, 2024$17.93K+64.4%
Q3 FY2024Sep 30, 2024$1.39K-87.5%
Q1 FY2024Mar 31, 2024$41.47K+830.1%
Q4 FY2023Dec 31, 2023$19.60K+2168.1%
Q3 FY2023Sep 30, 2023$10.91K+178.7%
Q2 FY2023Jun 30, 2023$11.05K+29.4%
Q1 FY2023Mar 31, 2023$4.46K+5272.3%
Q4 FY2022Dec 31, 2022$864+116.5%
Q3 FY2022Sep 30, 2022$3.91K+130.4%
Q2 FY2022Jun 30, 2022$8.55K+2047.0%
Q1 FY2022Mar 31, 2022$83-93.9%
Q4 FY2021Dec 31, 2021$399-75.2%
Q3 FY2021Sep 30, 2021$1.70K–
Q2 FY2021Jun 30, 2021$398–
Q1 FY2021Mar 31, 2021$1.36K–
Q4 FY2020Dec 31, 2020$1.61K–

More Nika Pharmaceuticals figures

See a number that looks wrong?